About this Research Topic
Mood and anxiety disorders, such as major depressive disorder (MDD) and bipolar disorder (BD), represent a major public health challenge. Nevertheless, until recently little was known about their pathophysiology. Although for researchers, scientists and clinicians, the pathophysiology of mood and anxiety disorders is an intriguing issue, delineating it in a clear way is far from easy. Many findings are still needed to draw its perfect architecture.
Since mood and anxiety disorders are often associated with anatomical and functional brain alterations, most of the pathophysiology will focus primarily on the brain. To investigate brain structures and functions, Neuroimaging will be the most appropriate tool.
In this Research Topic, we aim to collect worldwide researchers, scientists and clinicians findings on mood and anxiety disorders, especially concerning neuroimaging biomarkers (such as the state-dependent biomarker, trait biomarker, prediction biomarker). Our aim is for this Topic to help identify biomarkers in mood and anxiety disorders to facilitate diagnosis and the most appropriate treatment.
This Research Topic of Frontiers in Psychiatry welcomes original research and review articles regarding neuroimaging biomarkers of mood and anxiety disorders (including phobias and seasonal affective disorders).
Studies using the following techniques are particularly encouraged:
• Magnetic resonance imaging (MRI) (functional and structural MRI);
• Positron emission tomography (PET), single-photon emission computed tomography (SPECT);
• Magnetoencephalography (MEG);
• Near-infrared spectroscopy (NIRS);
• Electroencephalography (EEG);
• Machine learning and pattern recognition for neuroimaging biomarkers;
• Multimodal neuroimaging-related article;
• The neuroimaging biomarkers for antidepressant treatment, psychotherapy, ketamine, and transcranial magnetic stimulation.
Since mood and anxiety disorders are often associated with anatomical and functional brain alterations, most of the pathophysiology will focus primarily on the brain. To investigate brain structures and functions, Neuroimaging will be the most appropriate tool.
In this Research Topic, we aim to collect worldwide researchers, scientists and clinicians findings on mood and anxiety disorders, especially concerning neuroimaging biomarkers (such as the state-dependent biomarker, trait biomarker, prediction biomarker). Our aim is for this Topic to help identify biomarkers in mood and anxiety disorders to facilitate diagnosis and the most appropriate treatment.
This Research Topic of Frontiers in Psychiatry welcomes original research and review articles regarding neuroimaging biomarkers of mood and anxiety disorders (including phobias and seasonal affective disorders).
Studies using the following techniques are particularly encouraged:
• Magnetic resonance imaging (MRI) (functional and structural MRI);
• Positron emission tomography (PET), single-photon emission computed tomography (SPECT);
• Magnetoencephalography (MEG);
• Near-infrared spectroscopy (NIRS);
• Electroencephalography (EEG);
• Machine learning and pattern recognition for neuroimaging biomarkers;
• Multimodal neuroimaging-related article;
• The neuroimaging biomarkers for antidepressant treatment, psychotherapy, ketamine, and transcranial magnetic stimulation.
Keywords: neuroimaging, biomarker, treatment prediction, mood disorder, anxiety disorder
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
